Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
To invite people, share this page:
About This Webinar

BioMarin focusses on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission to bring new treatments to market that will make a big impact on small patient populations.

BioMarin has a dedicated and professional approach to researching and understanding the potential of gene therapy. This video details how hard our team works to continue the advancement of gene therapy research for rare diseases.

For any questions contact BioMarin Medical Information at medinfo@bmrn.com.

Language: English
Who can attend? Everyone
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts BioMarin Pharmaceutical Rare Opportunities, Personal Impact
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents